Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1981 1
1982 1
1984 3
1985 1
1986 2
1987 3
1988 3
1989 1
1990 5
1991 6
1992 2
1993 7
1994 14
1995 8
1996 10
1997 7
1998 18
1999 14
2000 24
2001 23
2002 28
2003 35
2004 55
2005 81
2006 103
2007 129
2008 139
2009 154
2010 160
2011 179
2012 214
2013 286
2014 276
2015 360
2016 374
2017 376
2018 387
2019 508
2020 582
2021 757
2022 852
2023 112
Text availability
Article attribute
Article type
Publication date

Search Results

5,613 results
Results by year
Filters applied: . Clear all
Page 1
ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts.
Yan M, Komatsu N, Muro R, Huynh NC, Tomofuji Y, Okada Y, Suzuki HI, Takaba H, Kitazawa R, Kitazawa S, Pluemsakunthai W, Mitsui Y, Satoh T, Okamura T, Nitta T, Im SH, Kim CJ, Kollias G, Tanaka S, Okamoto K, Tsukasaki M, Takayanagi H. Yan M, et al. Nat Immunol. 2022 Sep;23(9):1330-1341. doi: 10.1038/s41590-022-01285-0. Epub 2022 Aug 23. Nat Immunol. 2022. PMID: 35999392
Fructose-1,6-bisphosphatase 1 functions as a protein phosphatase to dephosphorylate histone H3 and suppresses PPARα-regulated gene transcription and tumour growth.
Wang Z, Li M, Jiang H, Luo S, Shao F, Xia Y, Yang M, Ren X, Liu T, Yan M, Qian X, He H, Guo D, Duan Y, Wu K, Wang L, Ji G, Shen Y, Li L, Zheng P, Dong B, Fang J, Zheng M, Liang T, Li H, Yu R, Xu D, Lu Z. Wang Z, et al. Among authors: yan m. Nat Cell Biol. 2022 Nov;24(11):1655-1665. doi: 10.1038/s41556-022-01009-4. Epub 2022 Oct 20. Nat Cell Biol. 2022. PMID: 36266488
Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial.
Peters S, Dziadziuszko R, Morabito A, Felip E, Gadgeel SM, Cheema P, Cobo M, Andric Z, Barrios CH, Yamaguchi M, Dansin E, Danchaivijitr P, Johnson M, Novello S, Mathisen MS, Shagan SM, Schleifman E, Wang J, Yan M, Mocci S, Voong D, Fabrizio DA, Shames DS, Riehl T, Gandara DR, Mok T. Peters S, et al. Among authors: yan m. Nat Med. 2022 Sep;28(9):1831-1839. doi: 10.1038/s41591-022-01933-w. Epub 2022 Aug 22. Nat Med. 2022. PMID: 35995953 Free PMC article. Clinical Trial.
Neutrophil reverse migration.
Xu Q, Zhao W, Yan M, Mei H. Xu Q, et al. Among authors: yan m. J Inflamm (Lond). 2022 Nov 24;19(1):22. doi: 10.1186/s12950-022-00320-z. J Inflamm (Lond). 2022. PMID: 36424665 Free PMC article. Review.
5,613 results